Evoke Pharma Quick Ratio 2012-2025 | EVOK

Historical quick ratio values for Evoke Pharma (EVOK) over the last 10 years.
Evoke Pharma Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2025-03-31 $0.02B $0.01B 1.50
2024-12-31 $0.02B $0.01B 1.62
2024-09-30 $0.01B $0.01B 1.39
2024-06-30 $0.01B $0.01B 1.22
2024-03-31 $0.01B $0.01B 1.33
2023-12-31 $0.01B $0.01B 0.66
2023-09-30 $0.01B $0.00B 3.27
2023-06-30 $0.01B $0.00B 4.04
2023-03-31 $0.01B $0.00B 5.71
2022-12-31 $0.01B $0.00B 6.91
2022-09-30 $0.01B $0.00B 6.94
2022-06-30 $0.01B $0.00B 10.45
2022-03-31 $0.01B $0.00B 6.45
2021-12-31 $0.01B $0.00B 7.38
2021-09-30 $0.01B $0.00B 8.18
2021-06-30 $0.02B $0.01B 2.77
2021-03-31 $0.02B $0.01B 3.03
2020-12-31 $0.01B $0.01B 1.20
2020-09-30 $0.01B $0.01B 1.00
2020-06-30 $0.00B $0.01B 0.00
2020-03-31 $0.00B $0.00B 0.00
2019-12-31 $0.00B $0.00B 0.00
2019-09-30 $0.00B $0.00B 0.00
2019-06-30 $0.00B $0.00B 0.00
2019-03-31 $0.00B $0.00B 0.00
2018-12-31 $0.00B $0.00B 0.00
2018-09-30 $0.00B $0.00B 0.00
2018-06-30 $0.00B $0.00B 0.00
2018-03-31 $0.00B $0.00B 0.00
2017-12-31 $0.00B $0.00B 0.00
2017-09-30 $0.00B $0.00B 0.00
2017-06-30 $0.00B $0.00B 0.00
2017-03-31 $0.00B $0.00B 0.00
2016-12-31 $0.00B $0.00B 0.00
2016-09-30 $0.00B $0.00B 0.00
2016-06-30 $0.00B $0.01B 0.00
2016-03-31 $0.00B $0.00B 0.00
2015-12-31 $0.00B $0.00B 0.00
2015-09-30 $0.00B $0.00B 0.00
2015-06-30 $0.00B $0.00B 0.00
2015-03-31 $0.00B $0.00B 0.00
2014-12-31 $0.00B $0.00B 0.00
2014-09-30 $0.00B $0.00B 0.00
2014-06-30 $0.00B $0.00B 0.00
2014-03-31 $0.00B $0.00B 0.00
2013-12-31 $0.00B $0.00B 0.00
2013-09-30 $0.00B $0.00B 0.00
2013-06-30 $0.00B $0.00B 0.00
2013-03-31 $0.00B 0.00
2012-12-31 $0.00B 0.00
2012-09-30 $0.00B 0.00
2012-06-30 $0.00B 0.00
2011-12-31 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.006B $0.010B
Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead product candidate, EVK-001, is in late stage clinical testing which is intended for the treatment of diabetic gastroparesis. Evoke Pharma, Inc. is based in San Diego, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.207B 6.94
Dr Reddy's Laboratories (RDY) India $11.921B 21.64
BridgeBio Pharma (BBIO) United States $6.260B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.794B 14.56
Bausch Health Cos (BHC) Canada $1.630B 1.20
Amphastar Pharmaceuticals (AMPH) United States $1.150B 7.66
Taysha Gene Therapies (TSHA) United States $0.612B 0.00
Personalis (PSNL) United States $0.408B 0.00
Assembly Biosciences (ASMB) United States $0.104B 0.00
Sol-Gel Technologies (SLGL) Israel $0.021B 0.00
Teligent (TLGT) United States $0.000B 0.00